Literature DB >> 19521660

Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria.

Thomas Müller1, H-J Bätza, A Beckert, C Bunzenthal, J H Cox, C M Freuling, A R Fooks, J Frost, L Geue, A Hoeflechner, D Marston, A Neubert, L Neubert, S Revilla-Fernández, E Vanek, A Vos, E Wodak, K Zimmer, T C Mettenleiter.   

Abstract

To eradicate rabies in foxes, almost 97 million oral rabies vaccine baits have been distributed in Germany and Austria since 1983 and 1986, respectively. Since 2007, no terrestrial cases have been reported in either country. The most widely used oral rabies vaccine viruses in these countries were SAD (Street Alabama Dufferin) strains, e.g. SAD B19 (53.2%) and SAD P5/88 (44.5%). In this paper, we describe six possible vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) detected during post-vaccination surveillance from 2001 to 2006, involving two different vaccines and different batches. Compared to prototypic vaccine strains, full-genome sequencing revealed between 1 and 5 single nucleotide alterations in the L gene in 5 of 6 SAD isolates, resulting in up to two amino acid substitutions. However, experimental infection of juvenile foxes showed that those mutations had no influence on pathogenicity. The cases described here, coming from geographically widely separated regions, do not represent a spatial cluster. More importantly, enhanced surveillance showed that the vaccine viruses involved did not become established in the red fox population. It seems that the number of reported vaccine virus-associated rabies cases is determined predominantly by the intensity of surveillance after the oral rabies vaccination campaign and not by the selection of strains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521660     DOI: 10.1007/s00705-009-0408-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Immunogenicity studies in carnivores using a rabies virus construct with a site-directed deletion in the phosphoprotein.

Authors:  Ad Vos; Karl-Klaus Conzelmann; Stefan Finke; Thomas Müller; Jens Teifke; Anthony R Fooks; Andreas Neubert
Journal:  Adv Prev Med       Date:  2011-09-21

2.  Wildlife reservoirs for vector-borne canine, feline and zoonotic infections in Austria.

Authors:  Georg G Duscher; Michael Leschnik; Hans-Peter Fuehrer; Anja Joachim
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-12-12       Impact factor: 2.674

3.  Molecular epidemiology of rabies virus in Poland.

Authors:  Anna Orłowska; Jan Franciszek Żmudziński
Journal:  Arch Virol       Date:  2014-03-14       Impact factor: 2.574

4.  Control and elimination of rabies in Croatia.

Authors:  Tomislav Bedeković; Ivana Lohman Janković; Ivana Šimić; Nina Krešić; Ivana Lojkić; Ivica Sučec; Emmanuelle Robardet; Florence Cliquet
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

5.  Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.

Authors:  Jennifer R Head; Ad Vos; Jesse Blanton; Thomas Müller; Richard Chipman; Emily G Pieracci; Julie Cleaton; Ryan Wallace
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

6.  Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.

Authors:  Conrad M Freuling; Verena Te Kamp; Antonia Klein; Maria Günther; Luca Zaeck; Madlin Potratz; Elisa Eggerbauer; Katharina Bobe; Christian Kaiser; Antje Kretzschmar; Steffen Ortmann; Peter Schuster; Adriaan Vos; Stefan Finke; Thomas Müller
Journal:  Viruses       Date:  2019-08-27       Impact factor: 5.048

7.  Spatio-temporal Use of Oral Rabies Vaccines in Fox Rabies Elimination Programmes in Europe.

Authors:  Thomas F Müller; Ronald Schröder; Patrick Wysocki; Thomas C Mettenleiter; Conrad M Freuling
Journal:  PLoS Negl Trop Dis       Date:  2015-08-17

Review 8.  Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review.

Authors:  Philippe Mähl; Florence Cliquet; Anne-Laure Guiot; Enel Niin; Emma Fournials; Nathalie Saint-Jean; Michel Aubert; Charles E Rupprecht; Sylvie Gueguen
Journal:  Vet Res       Date:  2014-08-10       Impact factor: 3.683

9.  A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.

Authors:  Xiaohui Liu; Youtian Yang; Zhaojin Sun; Jing Chen; Jun Ai; Can Dun; Zhen F Fu; Xuefeng Niu; Xiaofeng Guo
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 10.  Rabies in the Baltic States: Decoding a Process of Control and Elimination.

Authors:  Emmanuelle Robardet; Evelyne Picard-Meyer; Marianna Dobroštana; Ingrida Jaceviciene; Katrin Mähar; Zita Muižniece; Gediminas Pridotkas; Marius Masiulis; Enel Niin; Edvīns Olševskis; Florence Cliquet
Journal:  PLoS Negl Trop Dis       Date:  2016-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.